Unilever PLC (UL) 10-Year Financial Performance & Capital Metrics

UL • • Industrial / General

Consumer DefensiveHousehold ProductsPersonal Care & CosmeticsSkincare & Hair Care

AboutUnilever PLC operates as a fast-moving consumer goods company. It operates through Beauty & Personal Care, Foods & Refreshment, and Home Care segments. The Beauty & Personal Care segment provides skin care and hair care products, deodorants, and skin cleansing products. The Foods & Refreshment segment offers ice cream, soups, bouillons, seasonings, mayonnaise, ketchups, and tea categories. The Home Care segment provides fabric solutions and various cleaning products. The company offers its products under the Domestos, OMO, Seventh Generation, Ben & Jerry's, Knorr, Magnum, Wall's, Bango, the Vegetarian Butcher, Axe, Cif, Comfort, Dove, Lifebuoy, Lux, Rexona, Sunsilk, Equilibra, OLLY, Liquid I.V., SmartyPants, Onnit, Hellmann's, and Vaseline brands. Unilever PLC was incorporated in 1894 and is headquartered in London, the United Kingdom.Show more

Revenue $60.76B +1.9%
EBITDA $11.16B +3.8%
Net Income $5.74B -11.5%
EPS (Diluted) 2.29 -10.5%
Gross Margin 100% +136.8%
EBITDA Margin 18.36% +1.8%
Operating Margin 15.47% -5.5%
Net Margin 9.45% -13.1%
ROE 26.52% -13.2%
ROIC 15.28% -5.0%
Debt/Equity 1.36 -1.3%
Interest Coverage 8.41 -7.4%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Excellent 3Y average ROE of 31.3%
✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 2.7%
✓Healthy 5Y average net margin of 11.1%
✓Trading near 52-week high

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y2.29%

5Y3.17%

3Y5.03%

TTM2.48%

Profit (Net Income) CAGR

10Y1.06%

5Y0.42%

3Y-1.71%

TTM-13.62%

EPS CAGR

10Y2.49%

5Y1.36%

3Y-0.43%

TTM-11.78%

ROCE

10Y Avg21.95%

5Y Avg18.7%

3Y Avg19.12%

Latest17.69%

Peer Comparison

Skincare & Hair Care

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
AXILAXIL Brands, Inc.	52.99M	7.79	77.90	-4.51%	3.26%	8.85%	2.9%	0.08
ULUnilever PLC	141.09B	64.70	28.25	1.94%	10.16%	61.19%	5.51%	1.36
CLColgate-Palmolive Company	66.87B	82.96	23.64	3.31%	14.47%	234.81%	5.3%	15.65
PGThe Procter & Gamble Company	337.05B	144.24	22.16	0.29%	19.74%	31.31%	4.17%	0.68
SLSNSolesence, Inc. Common Stock	107.22M	1.52	21.71	40.35%	1.72%	6.21%		1.02
EPCEdgewell Personal Care Company	861.43M	18.44	9.36	0.09%	2.94%	4.13%	20.26%	0.87
UGUnited-Guardian, Inc.	28.76M	6.26	8.82	11.91%	19.48%	18.52%	10.55%

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	53.27B	52.71B	53.72B	50.98B	51.98B	50.72B	52.44B	60.07B	59.6B	60.76B
Revenue Growth %	0.1%	-0.01%	0.02%	-0.05%	0.02%	-0.02%	0.03%	0.15%	-0.01%	0.02%
Cost of Goods Sold+	30.81B	30.23B	30.48B	28.7B	29.1B	28.68B	30.26B	35.91B	34.43B	0
COGS % of Revenue	0.58%	0.57%	0.57%	0.56%	0.56%	0.57%	0.58%	0.6%	0.58%	-
Gross Profit+	22.46B	22.48B	23.23B	22.28B	22.88B	22.04B	22.18B	24.17B	25.18B	60.76B
Gross Margin %	0.42%	0.43%	0.43%	0.44%	0.44%	0.43%	0.42%	0.4%	0.42%	1%
Gross Profit Growth %	0.12%	0%	0.03%	-0.04%	0.03%	-0.04%	0.01%	0.09%	0.04%	1.41%
Operating Expenses+	14.95B	14.68B	14.27B	9.64B	14.17B	13.74B	13.48B	13.41B	15.42B	51.36B
OpEx % of Revenue	0.28%	0.28%	0.27%	0.19%	0.27%	0.27%	0.26%	0.22%	0.26%	0.85%
Selling, General & Admin	14.06B	13.8B	12.93B	11.94B	12.12B	11.88B	12.56B	14.44B	15.13B	71M
SG&A % of Revenue	0.26%	0.26%	0.24%	0.23%	0.23%	0.23%	0.24%	0.24%	0.25%	0%
Research & Development	1B	978M	900M	900M	840M	800M	847M	908M	949M	0
R&D % of Revenue	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	-
Other Operating Expenses	-121M	-94M	447M	-3.2B	1.21B	1.05B	77M	-1.94B	-666M	51.29B
Operating Income+	7.51B	7.8B	8.96B	12.64B	8.71B	8.3B	8.7B	10.76B	9.76B	9.4B
Operating Margin %	0.14%	0.15%	0.17%	0.25%	0.17%	0.16%	0.17%	0.18%	0.16%	0.15%
Operating Income Growth %	-0.06%	0.04%	0.15%	0.41%	-0.31%	-0.05%	0.05%	0.24%	-0.09%	-0.04%
EBITDA+	8.88B	9.27B	10.49B	14.65B	10.67B	10.32B	10.45B	11.82B	10.75B	11.16B
EBITDA Margin %	0.17%	0.18%	0.2%	0.29%	0.21%	0.2%	0.2%	0.2%	0.18%	0.18%
EBITDA Growth %	-0.02%	0.04%	0.13%	0.4%	-0.27%	-0.03%	0.01%	0.13%	-0.09%	0.04%
D&A (Non-Cash Add-back)	1.37B	1.46B	1.54B	2.01B	1.96B	2.02B	1.75B	1.07B	990M	1.76B
EBIT	7.39B	7.71B	9.4B	9.33B	9.92B	9.36B	9.64B	9.51B	10.12B	11.25B
Net Interest Income+	-317M	-353M	-521M	-596M	-539M	-471M	-361M	-508M	-633M	-680M
Interest Income	317M	353M	521M	135M	224M	232M	147M	281M	442M	438M
Interest Expense	548M	568M	565M	731M	763M	703M	498M	789M	1.07B	1.12B
Other Income/Expense	-295M	-332M	-831M	-279M	-419M	-307M	-146M	-418M	-419M	-531M
Pretax Income+	7.22B	7.47B	8.13B	12.36B	8.29B	8B	8.56B	10.34B	9.34B	8.87B
Pretax Margin %	0.14%	0.14%	0.15%	0.24%	0.16%	0.16%	0.16%	0.17%	0.16%	0.15%
Income Tax+	1.96B	1.92B	1.67B	2.57B	2.26B	1.92B	1.94B	2.07B	2.2B	2.5B
Effective Tax Rate %	0.68%	0.69%	0.74%	0.76%	0.68%	0.7%	0.71%	0.74%	0.69%	0.65%
Net Income+	4.91B	5.18B	6.02B	9.37B	5.63B	5.58B	6.05B	7.64B	6.49B	5.74B
Net Margin %	0.09%	0.1%	0.11%	0.18%	0.11%	0.11%	0.12%	0.13%	0.11%	0.09%
Net Income Growth %	-0.05%	0.06%	0.16%	0.56%	-0.4%	-0.01%	0.08%	0.26%	-0.15%	-0.11%
Net Income (Continuing)	5.26B	5.55B	6.46B	9.79B	6.03B	6.07B	6.62B	8.27B	7.14B	6.37B
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	643M	626M	758M	720M	694M	2.39B	2.64B	2.68B	2.66B	2.56B
EPS (Diluted)+	1.72	1.82	2.14	3.48	2.14	2.12	2.32	2.99	2.56	2.29
EPS Growth %	-0.04%	0.06%	0.18%	0.63%	-0.39%	-0.01%	0.09%	0.29%	-0.14%	-0.11%
EPS (Basic)	1.73	1.83	2.15	3.48	2.15	2.13	2.33	3.00	2.58	2.30
Diluted Shares Outstanding	2.86B	2.85B	2.81B	2.69B	2.63B	2.63B	2.61B	2.56B	2.53B	2.51B
Basic Shares Outstanding	2.85B	2.85B	2.81B	2.69B	2.63B	2.63B	2.61B	2.56B	2.53B	2.51B
Dividend Payout Ratio	0.68%	0.7%	0.65%	0.43%	0.75%	0.77%	0.74%	0.57%	0.67%	0.75%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	12.69B	13.88B	16.98B	15.48B	16.43B	16.16B	17.4B	19.16B	17.9B	19.19B
Cash & Short-Term Investments	2.64B	3.98B	4.09B	4.1B	5.09B	6.3B	4.5B	5.52B	6.11B	7.63B
Cash Only	2.3B	3.38B	3.32B	3.23B	4.18B	5.55B	3.42B	4.33B	4.16B	6.14B
Short-Term Investments	337M	599M	770M	874M	907M	749M	1.08B	1.2B	1.73B	1.49B
Accounts Receivable	5.07B	5.31B	5.22B	6.95B	6.7B	3.43B	4.47B	4.54B	4.94B	5.12B
Days Sales Outstanding	34.76	36.77	35.46	49.79	47.01	24.7	31.11	27.61	30.24	30.74
Inventory	4.33B	4.28B	3.96B	4.3B	4.16B	4.46B	4.68B	5.93B	5.12B	5.18B
Days Inventory Outstanding	51.36	51.65	47.44	54.69	52.23	56.78	56.49	60.29	54.27	-
Other Current Assets	5.71B	5.92B	7.99B	7.27B	7.59B	7.28B	3.26B	10.62B	1.74B	689M
Total Non-Current Assets+	39.61B	42.55B	43.3B	43.98B	48.38B	51.5B	57.69B	58.66B	57.36B	60.56B
Property, Plant & Equipment	11.06B	11.67B	10.41B	10.35B	12.06B	10.56B	10.35B	10.77B	10.7B	11.67B
Fixed Asset Turnover	4.82x	4.52x	5.16x	4.93x	4.31x	4.80x	5.07x	5.58x	5.57x	5.21x
Goodwill	16.21B	17.62B	16.88B	17.34B	18.07B	18.94B	20.33B	21.61B	21.11B	22.31B
Intangible Assets	8.85B	9.81B	11.52B	12.15B	12.96B	16B	18.26B	18.88B	18.36B	18.59B
Long-Term Investments	341M	270M	188M	-232M	-33M	5M	-91M	-293M	1.87B	618M
Other Non-Current Assets	1.97B	1.81B	3.22B	3.25B	3.98B	4.52B	7.38B	6.65B	4.21B	6.71B
Total Assets+	52.3B	56.43B	60.28B	59.46B	64.81B	67.66B	75.09B	77.82B	75.27B	79.75B
Asset Turnover	1.02x	0.93x	0.89x	0.86x	0.80x	0.75x	0.70x	0.77x	0.79x	0.76x
Asset Growth %	0.09%	0.08%	0.07%	-0.01%	0.09%	0.04%	0.11%	0.04%	-0.03%	0.06%
Total Current Liabilities+	20.02B	20.56B	23.18B	19.77B	20.98B	20.59B	24.78B	25.43B	23.51B	25.23B
Accounts Payable	8.3B	8.59B	8.22B	9.12B	9.19B	8.38B	8.9B	11.1B	10.36B	10.26B
Days Payables Outstanding	98.29	103.73	98.39	115.99	115.26	106.57	107.31	112.84	109.78	-
Short-Term Debt	4.34B	5.27B	7.69B	2.95B	4.07B	3.91B	6.7B	5.23B	4.57B	5.88B
Deferred Revenue (Current)	0	-1000K	1000K	0	1000K	0	1000K	0	0	0
Other Current Liabilities	4.34B	4.37B	4.65B	4.27B	3.57B	365M	-1.72B	6.27B	6.12B	2.4B
Current Ratio	0.63x	0.68x	0.73x	0.78x	0.78x	0.78x	0.70x	0.75x	0.76x	0.76x
Quick Ratio	0.42x	0.47x	0.56x	0.57x	0.58x	0.57x	0.51x	0.52x	0.54x	0.56x
Cash Conversion Cycle	-12.17	-15.31	-15.48	-11.51	-16.02	-25.09	-19.71	-24.94	-25.27	-
Total Non-Current Liabilities+	16.2B	18.89B	22.72B	27.39B	29.94B	29.41B	30.57B	30.69B	31B	31.96B
Long-Term Debt	9.42B	10.93B	16.01B	21.26B	21.82B	21.09B	21.33B	21.8B	22.63B	23.29B
Capital Lease Obligations	158M	134M	120M	1.59B	1.54B	1.39B	1.28B	1.07B	1.06B	1.16B
Deferred Tax Liabilities	1.74B	2.06B	1.91B	1.92B	2.57B	3.17B	4.53B	4.38B	4B	4.34B
Other Non-Current Liabilities	273M	5.76B	4.68B	2.64B	0	235M	275M	3.45B	3.31B	3.17B
Total Liabilities	36.22B	39.45B	45.9B	47.16B	50.92B	50B	55.35B	56.12B	54.5B	57.2B
Total Debt+	13.96B	16.59B	24.43B	24.89B	28.26B	26.77B	29.67B	28.44B	28.59B	30.66B
Net Debt	11.66B	13.21B	21.11B	21.66B	24.07B	21.22B	26.26B	24.11B	24.43B	24.52B
Debt / Equity	0.87x	0.98x	1.70x	2.02x	2.03x	1.52x	1.50x	1.31x	1.38x	1.36x
Debt / EBITDA	1.57x	1.79x	2.33x	1.70x	2.65x	2.59x	2.84x	2.41x	2.66x	2.75x
Net Debt / EBITDA	1.31x	1.43x	2.01x	1.48x	2.26x	2.06x	2.51x	2.04x	2.27x	2.20x
Interest Coverage	13.71x	13.73x	15.85x	17.29x	11.41x	11.81x	17.47x	13.63x	9.08x	8.41x
Total Equity+	16.08B	16.98B	14.39B	12.29B	13.89B	17.66B	19.75B	21.7B	20.76B	22.55B
Equity Growth %	0.13%	0.06%	-0.15%	-0.15%	0.13%	0.27%	0.12%	0.1%	-0.04%	0.09%
Book Value per Share	5.63	5.95	5.11	4.56	5.29	6.71	7.57	8.48	8.20	9.00
Total Shareholders' Equity	15.44B	16.36B	13.63B	11.57B	13.19B	15.27B	17.11B	19.02B	18.1B	19.99B
Common Stock	484M	484M	484M	464M	420M	92M	92M	92M	88M	88M
Retained Earnings	22.62B	23.18B	26.65B	26.27B	18.21B	22.55B	46.74B	50.25B	47.05B	49.72B
Treasury Stock	0	0	0	0	0	0	-3.41B	-4.81B	-6.24B	0
Accumulated OCI	-3.48B	-3.28B	-4.42B	-5.04B	-11.98B	-80.85B	-79.05B	-79.56B	-75.64B	-80.37B
Minority Interest	643M	626M	758M	720M	694M	2.39B	2.64B	2.68B	2.66B	2.56B

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	7.33B	7.05B	7.88B	7.32B	8.11B	9.06B	7.97B	7.28B	9.43B	9.52B
Operating CF Margin %	0.14%	0.13%	0.15%	0.14%	0.16%	0.18%	0.15%	0.12%	0.16%	0.16%
Operating CF Growth %	0.32%	-0.04%	0.12%	-0.07%	0.11%	0.12%	-0.12%	-0.09%	0.29%	0.01%
Net Income	4.91B	5.18B	6.02B	9.37B	5.63B	5.58B	6.05B	7.64B	6.49B	5.74B
Depreciation & Amortization	1.37B	1.46B	2.02B	2.01B	1.96B	2.02B	1.75B	1.51B	1.58B	1.76B
Stock-Based Compensation	150M	198M	284M	196M	151M	108M	161M	177M	212M	324M
Deferred Taxes	0	0	0	0	294.06M	0	0	0	0	0
Other Non-Cash Items	1.03B	-131M	157M	-2.49B	206.94M	813M	63M	-1.62B	335M	2.1B
Working Capital Changes	-127M	332M	-610M	-1.77B	-132M	538M	-47M	-422M	814M	-404M
Change in Receivables	2M	142M	-506M	-1.3B	-445M	1.13B	-307M	-1.85B	768M	-206M
Change in Inventory	-129M	190M	-104M	-471M	313M	-587M	-458M	-1.4B	340M	-198M
Change in Payables	0	0	0	0	127.36M	0	733.88M	2.73B	0	0
Cash from Investing+	-3.54B	-3.19B	-5.88B	4.64B	-2.24B	-1.48B	-3.25B	2.45B	-2.29B	-625M
Capital Expenditures	-1.87B	-1.8B	-1.51B	-1.33B	-1.32B	-863M	-1.11B	-1.46B	-1.5B	-1.74B
CapEx % of Revenue	0.04%	0.03%	0.03%	0.03%	0.03%	0.02%	0.02%	0.02%	0.03%	0.03%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	225M	347M	526M	7.31B	380.13M	160M	198.97M	290.21M	305M	923M
Cash from Financing+	-3.03B	-3.07B	-2.02B	-12.11B	-4.67B	-5.8B	-7.1B	-8.89B	-7.19B	-6.94B
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-3.33B	-3.61B	-3.92B	-4.07B	-4.36B	-4.28B	-4.48B	-4.33B	-4.36B	-4.32B
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-966M	-1.01B	-1.38B	-1.75B	-1.44B	-1.79B	-254M	-1.84B	-1.82B	-1.76B
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	5.46B	5.24B	6.37B	5.99B	6.79B	8.2B	6.86B	5.83B	7.92B	7.78B
FCF Margin %	0.1%	0.1%	0.12%	0.12%	0.13%	0.16%	0.13%	0.1%	0.13%	0.13%
FCF Growth %	0.5%	-0.04%	0.21%	-0.06%	0.13%	0.21%	-0.16%	-0.15%	0.36%	-0.02%
FCF per Share	1.91	1.84	2.26	2.22	2.59	3.12	2.63	2.28	3.13	3.10
FCF Conversion (FCF/Net Income)	1.49x	1.36x	1.31x	0.78x	1.44x	1.62x	1.32x	0.95x	1.45x	1.66x
Interest Paid	0	0	0	0	0	0	0	0	0	1.08B
Taxes Paid	0	0	0	0	0	0	0	0	0	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	32.35%	31.36%	38.4%	70.23%	42.98%	35.39%	32.35%	36.88%	30.55%	26.52%
Return on Invested Capital (ROIC)	21.44%	20.2%	20.45%	27.3%	18.17%	16.21%	15.38%	17.57%	16.08%	15.28%
Gross Margin	42.17%	42.65%	43.25%	43.7%	44.01%	43.45%	42.3%	40.23%	42.24%	100%
Net Margin	9.21%	9.83%	11.21%	18.38%	10.82%	11%	11.53%	12.72%	10.88%	9.45%
Debt / Equity	0.87x	0.98x	1.70x	2.02x	2.03x	1.52x	1.50x	1.31x	1.38x	1.36x
Interest Coverage	13.71x	13.73x	15.85x	17.29x	11.41x	11.81x	17.47x	13.63x	9.08x	8.41x
FCF Conversion	1.49x	1.36x	1.31x	0.78x	1.44x	1.62x	1.32x	0.95x	1.45x	1.66x
Revenue Growth	9.98%	-1.05%	1.9%	-5.09%	1.96%	-2.42%	3.39%	14.55%	-0.78%	1.94%

Revenue by Geography

	2018	2019	2020	2021	2022	2023	2024
Asia Pacific And Africa	-	-	-	-	27.5B	26.23B	25.99B
Asia Pacific And Africa Growth	-	-	-	-	-	-4.62%	-0.93%
Americas	-	-	-	-	20.91B	21.53B	22.49B
Americas Growth	-	-	-	-	-	2.99%	4.46%
North America	-	-	-	10.63B	13B	13.13B	13.38B
North America Growth	-	-	-	-	22.33%	1.00%	1.92%
Europe	12.09B	11.37B	11.2B	11.34B	11.66B	11.84B	12.28B
Europe Growth	-	-5.99%	-1.45%	1.18%	2.89%	1.50%	3.72%
Latin America	-	-	-	6.22B	7.91B	8.4B	9.11B
Latin America Growth	-	-	-	-	27.15%	6.27%	8.43%

Frequently Asked Questions

Valuation & Price

Unilever PLC (UL) has a price-to-earnings (P/E) ratio of 28.3x. This suggests investors expect higher future growth.

Growth & Financials

Unilever PLC (UL) reported $120.06B in revenue for fiscal year 2024. This represents a 158% increase from $46.47B in 2011.

Unilever PLC (UL) grew revenue by 1.9% over the past year. Growth has been modest.

Yes, Unilever PLC (UL) is profitable, generating $12.20B in net income for fiscal year 2024 (9.5% net margin).

Dividend & Returns

Yes, Unilever PLC (UL) pays a dividend with a yield of 2.66%. This makes it attractive for income-focused investors.

Unilever PLC (UL) has a return on equity (ROE) of 26.5%. This is excellent, indicating efficient use of shareholder capital.

Unilever PLC (UL) generated $14.47B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...